|
Everolimus Teva 2,5 mg tbl 90x2,5 mg (blis.OPA/Al/PVC/Al)
2,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 5 mg tbl 10x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 5 mg tbl 30x1x5 mg (blis.OPA/Al/PVC/Al-jednotliv.bal.)
5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 5 mg tbl 30x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 5 mg tbl 50x1x5 mg (blis.OPA/Al/PVC/Al-jednotliv.bal.)
5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 5 mg tbl 60x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 5 mg tbl 90x5 mg (blis.OPA/Al/PVC/Al)
5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 7,5 mg tbl 10x7,5 mg (blis.OPA/Al/PVC/Al)
7,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 7,5 mg tbl 30x1x7,5 mg (blis.OPA/Al/PVC/Al-jednotliv.bal.)
7,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 7,5 mg tbl 30x7,5 mg (blis.OPA/Al/PVC/Al)
7,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 7,5 mg tbl 50x1x7,5 mg (blis.OPA/Al/PVC/Al-jednotliv.bal.)
7,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 7,5 mg tbl 60x7,5 mg (blis.OPA/Al/PVC/Al)
7,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Teva 7,5 mg tbl 90x7,5 mg (blis.OPA/Al/PVC/Al)
7,5 mg
|
Tableta |
L01EG02
|
TEVA Pharmaceuticals Slovakia s.r.o. |
—
|
|
Everolimus Vipharm 10 mg tablety tbl 10x10 mg (blis.Al/Al)
10 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 10 mg tablety tbl 30x10 mg (blis.Al/Al)
10 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 10 mg tablety tbl 90x10 mg (blis.Al/Al)
10 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 2,5 mg tablety tbl 30x2,5 mg (blis.Al/Al)
2,5 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 2,5 mg tablety tbl 90x2,5 mg (blis.Al/Al)
2,5 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 5 mg tablety tbl 10x5 mg (blis.Al/Al)
5 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 5 mg tablety tbl 30x5 mg (blis.Al/Al)
5 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Everolimus Vipharm 5 mg tablety tbl 90x5 mg (blis.Al/Al)
5 mg
|
Tableta |
L01EG02
|
Vipharm S.A. |
—
|
|
Gevesla 100 mg cps mol 30x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
100 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|
|
Gevesla 100 mg cps mol 60x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
100 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|
|
Gevesla 150 mg cps mol 30x1x150 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.
150 mg
|
Mäkká kapsula |
L01EX09
|
Sandoz Pharmaceuticals d.d. |
—
|